Literature DB >> 19508608

Insulin sensitivity and body composition in children with classical and nonclassical congenital adrenal hyperplasia.

R M Williams1, A Deeb, K K Ong, W Bich, P R Murgatroyd, I A Hughes, C L Acerini.   

Abstract

BACKGROUND: Reduced insulin sensitivity and increased fat mass have been reported in children and adults with congenital adrenal hyperplasia (CAH). To understand the potential mechanisms underlying these differences, we assessed insulin sensitivity and body composition in children with classical or nonclassical (late-presenting) CAH compared with normal controls. SUBJECTS AND METHODS: Thirty-seven children with CAH (26 classical and 11 nonclassical) median (range) age 9.4 year (0.5-15.8) were compared with 41 healthy control children age 11.0 year (3.2-17.1). All children had an overnight fasting blood sample and body composition assessed by DEXA. Pubertal children (14 CAH and 19 controls) also had an oral glucose tolerance test. Classical and nonclassical CAH groups were each compared with controls, adjusting for age, gender and pubertal status. Results Classical CAH children had more fat mass than controls (P = 0.03), while nonclassical CAH children had more lean mass (P = 0.006) and higher systolic blood pressure (P = 0.003) than control children. Among pubertal children, nonclassical CAH children had higher mean insulin (0-120 min; P = 0.04), stimulated insulin (0-30 min; P = 0.02), 120 min insulin (P = 0.004) and 120 min glucose levels (P = 0.03) than controls, but no difference in disposition index. DISCUSSION: Greater body fat in classical (early-presenting) CAH children could reflect the effects of lifetime glucocorticoid therapy. In contrast, the greater lean mass and parameters of insulin resistance in nonclassical (late-presenting) CAH children likely indicate the adverse metabolic effects of prolonged postnatal androgen excess.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19508608     DOI: 10.1111/j.1365-2265.2009.03587.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  17 in total

1.  Obesity in children with congenital adrenal hyperplasia in the Minnesota cohort: importance of adjusting body mass index for height-age.

Authors:  Kyriakie Sarafoglou; Gregory P Forlenza; O Yaw Addo; Jennifer Kyllo; Aida Lteif; P C Hindmarsh; Anna Petryk; Maria Teresa Gonzalez-Bolanos; Bradley S Miller; William Thomas
Journal:  Clin Endocrinol (Oxf)       Date:  2017-03-28       Impact factor: 3.478

Review 2.  Clinical perspectives in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency.

Authors:  Krupali Bulsari; Henrik Falhammar
Journal:  Endocrine       Date:  2016-12-07       Impact factor: 3.633

3.  Increased large artery intima media thickness in adolescents with either classical or non-classical congenital adrenal hyperplasia.

Authors:  M Wasniewska; A Balsamo; M Valenzise; A Manganaro; G Faggioli; S Bombaci; V Conti; M Ferri; T Aversa; A Cicognani; F De Luca
Journal:  J Endocrinol Invest       Date:  2011-12-21       Impact factor: 4.256

4.  Carotid intima media thickness and other cardiovascular risk factors in children with congenital adrenal hyperplasia.

Authors:  N H Amr; A Y Ahmed; Y A Ibrahim
Journal:  J Endocrinol Invest       Date:  2014-08-12       Impact factor: 4.256

5.  Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia.

Authors:  Gabriela P Finkielstain; Mimi S Kim; Ninet Sinaii; Miki Nishitani; Carol Van Ryzin; Suvimol C Hill; James C Reynolds; Reem M Hanna; Deborah P Merke
Journal:  J Clin Endocrinol Metab       Date:  2012-09-18       Impact factor: 5.958

Review 6.  Clinical outcomes in the management of congenital adrenal hyperplasia.

Authors:  Henrik Falhammar; Marja Thorén
Journal:  Endocrine       Date:  2012-01-07       Impact factor: 3.633

Review 7.  Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome.

Authors:  Henrik Falhammar; Anna Nordenström
Journal:  Endocrine       Date:  2015-06-17       Impact factor: 3.633

8.  Mineralocorticoid deficiency and treatment in congenital adrenal hyperplasia.

Authors:  Raja Padidela; Peter C Hindmarsh
Journal:  Int J Pediatr Endocrinol       Date:  2010-05-04

9.  The Challenges of Cortisol Replacement Therapy in Childhood: Observations from a Case Series of Children Treated with Modified-Release Hydrocortisone.

Authors:  Julie Park; Urmi Das; Mohammed Didi; Renuka Ramakrishnan; Matthew Peak; Paul Newland; Joanne Blair
Journal:  Paediatr Drugs       Date:  2018-12       Impact factor: 3.022

10.  Cardiovascular Disease Risk Factors and Metabolic Morbidity in a Longitudinal Study of Congenital Adrenal Hyperplasia.

Authors:  Ahmed Torky; Ninet Sinaii; Smita Jha; Jay Desai; Diala El-Maouche; Ashwini Mallappa; Deborah P Merke
Journal:  J Clin Endocrinol Metab       Date:  2021-11-19       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.